- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06334341
A Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP) (MOST:PrEP)
March 26, 2024 updated by: Henry Ford Health System
A Multilevel, Multiphase Optimization Strategy for PrEP: Patients and Providers in Primary Care
What is known: There are 1.2 million people in the US who meet the indications for PrEP; yet, disparities exist in uptake.
For example, only 9% of Black and 16% of Latino individuals, compared to 65% of White individuals, have been prescribed PrEP.
At Henry Ford Health (HFH) system, only 10% of eligible patients have been prescribed PrEP.
Primary care is an ideal setting for PrEP to be offered as an HIV prevention method since providers see large numbers of patients who are HIV negative, with some who are at increased risk for HIV, and the primary care setting is often the point of entry to the healthcare system.
The multiphase optimization strategy (MOST) framework is a novel, innovative way to identify an efficient intervention.
What will be done: In this optimization trial, the investigators will test the effectiveness of intervention components, alone and in combination, on new PrEP prescriptions in primary care at HFH.
First, feedback will be generated on context-specific (system and individual level) factors for intervention component delivery via focus groups with providers (n=15) and patients eligible for PrEP (n=30).
Then, four intervention components will be tested in an optimization trial, with 16 conditions being implemented at 32 clinics.
Finally, feedback will be generated on the factors that affected implementation via semi-structured interviews with providers (n=30) and patients (n=30).
Participants will be primary care providers (PCPs) and patients eligible for PrEP in Henry Ford Health System.
Clinics will be randomized (yes/no) to receive any combination of provider and patient intervention components.
Provider intervention components include computer-based simulation training and/or best practice alerts delivered via the electronic health record (EHR).
Patient intervention components include HIV risk assessment and/or PrEP informational video - both delivered via the EHR.
Primary outcome is the rate of new PrEP prescriptions at the clinic level.
Secondary outcomes will include PrEP maintenance, number of HIV tests ordered by a PCP, and number of PCPs trained.
Sub analyses will test which factors moderate (e.g., patient sex, race, age, gender, sexual orientation) or mediate (e.g., perceived HIV risk, provider and patient PrEP knowledge) PrEP uptake, focusing on priority populations and disparities in rates of PrEP prescription.
Implications: 1) Understanding which intervention components lead to increased PrEP prescriptions will represent an important advance in HIV prevention efforts.
2) Optimizing a multi-level intervention for providers and patients to increase PrEP prescriptions would lead to a new, efficient, evidence-based option.
3) Determining what factors are related to PrEP uptake will help reduce disparities in PrEP initiation among those most in need.
4) Understanding the context specific factors related to intervention component implementation will help identify best methods for replication/adaptation in other healthcare systems.
Study Overview
Status
Enrolling by invitation
Conditions
Study Type
Interventional
Enrollment (Estimated)
1380
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Henry Ford Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Provider:≥ 18-years old
- Provider: employed at HFH as a primary care provider
- Provider: eligible to write prescriptions in the state of Michigan
- Patient: ≥ 18 years old
- Patient: have an appointment with a Henry Ford primary care clinic during the study period
- Patient: have an EHR account
- Patient: meet the indications for PrEP
Exclusion Criteria:
- Provider: not a HFH primary care provider
- Provider: does not have prescribing privileges in the state of Michigan
- Patient: currently prescribed or taking PrEP
- Patient: living with HIV
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: No intervention
|
|
Experimental: Video
Patient PrEP Video only
|
A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
|
Experimental: Risk Assessment
Patient Risk Assessment only
|
A risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
|
Experimental: Risk Assessment and Video
Patient Risk Assessment and Patient PrEP Video
|
A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
A risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
|
Experimental: Best Practice Alert
Best Practice Alert only
|
A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
|
Experimental: Best Practice Alert and Video
Best Practice Alert and Patient PrEP Video
|
A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
|
Experimental: Best Practice Alert and Risk Assessment
Best Practice Alert and Patient Risk Assessment
|
A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
|
Experimental: Best Practice Alert, Risk Assessment and Video
Best Practice Alert, Patient Risk Assessment, and Patient PrEP Video
|
A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
A risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
|
Experimental: Training
Provider Training
|
A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory.
This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
|
Experimental: Training and Video
Provider Training and Patient PrEP Video
|
A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory.
This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
|
Experimental: Training and Risk Assessment
Provider Training and Patient Risk Assessment
|
A risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory.
This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
|
Experimental: Training, Risk Assessment, and Video
Provider Training, Patient Risk Assessment, and Patient PrEP Video
|
A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
A risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory.
This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
|
Experimental: Training and Best Practice Alert
Provider Training and Best Practice Alert
|
A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory.
This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
|
Experimental: Training, Best Practice Alert, and Video
Provider Training, Best Practice Alert, and Patient PrEP Video
|
A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory.
This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
|
Experimental: Training, Best Practice Alert, and Risk Assessment
Provider Training, Best Practice Alert, and Patient Risk Assessment
|
A risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory.
This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
|
Experimental: Training, Best Practice Alert, Risk Assessment, and Video
Provider Training, Best Practice Alert, Patient Risk Assessment, and Patient PrEP Video
|
A short informational video, tailored to the local Detroit context with themes that will focus on introducing PrEP, stigma surrounding taking PrEP, and potential barriers and how to overcome them.
A risk assessment tool that considers the behaviors - i.e., types of sexual activities, protective behaviors (condoms, PrEP, ART), and other factors (HIV status, sexually transmitted infections) of the respondent.
A Best Practice Alert will alert providers to patients who are part of the Centers for Disease Control and Prevention PrEP priority populations.
A Computer-Based Simulation training for providers, based on the Centers for Disease Control and Prevention "Guide for Healthcare Professional: Discussing Sexual Health with Your Patients", current PrEP information, and the Social Cognitive Theory.
This is a single-session, 30-minute training module contains educational information with animated narration about PrEP, how to take a sexual health history, understanding internal bias, potential patient barriers to PrEP as well as recorded video-simulated encounters, in which providers view different types of patient/provider interactions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinic-Level PrEP Prescription
Time Frame: Year 1 and Year 5 electronic health record data pull.
|
The number of new PrEP prescriptions written within 6-months of the study-associated patient appointment.
It is defined as a new documented prescription in the patient electronic health records for PrEP (daily pill or injection) at any date between the initial study primary care appointment plus 180 days.
|
Year 1 and Year 5 electronic health record data pull.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PrEP Knowledge
Time Frame: Provider pre-post survey and patient demographic and 6- month surveys
|
PrEP knowledge will be measured by 6-items assessing PrEP dosing frequency, approved FDA medications, HIV antibody testing prior to PrEP initiation, HIV testing frequency while on PrEP, contraindications to prescribing PrEP, and routine standard of care practices for patients taking PrEP
|
Provider pre-post survey and patient demographic and 6- month surveys
|
PrEP awareness
Time Frame: Provider pre-post survey and patient demographic and 6- month surveys
|
PrEP awareness will be measured by the statement "there is a pill (drug/medication) that a person can take to prevent transmission of HIV from an infected (HIV positive) sex partner to an uninfected (HIV negative) partner."
with responses true/false, don't know.
|
Provider pre-post survey and patient demographic and 6- month surveys
|
PrEP prescribing comfort
Time Frame: Pre-intervention and immediately after the intervention for providers
|
PrEP prescribing comfort will be measured by 9- items from the PrEP Information, Motivation, and Behaviors survey.
|
Pre-intervention and immediately after the intervention for providers
|
PrEP prescribing intentions
Time Frame: Pre-intervention and immediately after the intervention for providers
|
PrEP prescribing intentions will be measured by 8- items from the PrEP Information, Motivation, and Behaviors survey.
|
Pre-intervention and immediately after the intervention for providers
|
Perceived HIV risk
Time Frame: Patient demographic and 6- month surveys
|
Patients perceived HIV risk will be measured by 10- items from the Perceived Risk of HIV scale.
|
Patient demographic and 6- month surveys
|
Preferences for patient- provider communication
Time Frame: Patient demographic and 6- month surveys
|
Preferences for patient-provider communications will be measured by the Control Preferences Scale, the Communication Assessment Tool, and the Patient-Practitioner Orientation Scale.
|
Patient demographic and 6- month surveys
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elizabeth Lockhart, PhD, Henry Ford Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 21, 2024
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
April 1, 2028
Study Registration Dates
First Submitted
March 18, 2024
First Submitted That Met QC Criteria
March 26, 2024
First Posted (Actual)
March 28, 2024
Study Record Updates
Last Update Posted (Actual)
March 28, 2024
Last Update Submitted That Met QC Criteria
March 26, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- HIV Infections
- Urogenital Diseases
- Genital Diseases
- HIV Seropositivity
Other Study ID Numbers
- R01MD018523-01A1 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Seropositivity
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Therapeutic ConceptsJanssen Scientific Affairs, LLCUnknown
Clinical Trials on PrEP Informational Video
-
The Alternative Sexualities Health Research AllianceRecruitingPre-Exposure ProphylaxisUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalCompletedCOVID-19 | Vaccine RefusalCanada
-
Mersin UniversityCompleted
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI); Southern Methodist University; Parkland Health...TerminatedHuman Papillomavirus VaccinesUnited States
-
University of Illinois at ChicagoNational Cancer Institute (NCI)RecruitingHigh Risk for Breast CancerUnited States
-
Zeev RosbergerCompleted
-
Johns Hopkins Bloomberg School of Public HealthYale UniversityRecruitingHIV | Violence, Gender-Based | Pre-Exposure ProphylaxisUnited States
-
VA Office of Research and DevelopmentCompletedStroke | HypertensionUnited States
-
Karadeniz Technical UniversityCompletedChild | Pain, Procedural | Phlebotomy | VenipunctureTurkey
-
University of VirginiaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Exposed PregnancyUnited States